“Optimizing Targeted Therapy for Metastatic Melanoma: A Combination of Encorafenib and Trametinib Beyond Standard Protocols”. Dermatology Reports (April 15, 2025). Accessed June 18, 2025. https://journals.pagepress.org/dr/article/view/10036.